BOPA is delighted to be working with UKCPA and Rheumatology Pharmacists UK on a joint Biosimilars study day in London on 1st November.
Full details of the day – ‘Biosimilars – How will Pharmacy face the challenge?’ including registration can be found at www.pharman.co.uk/events/2017/11/biosimilars-how-will-pharmacy-manage-the-challenge
The agenda will be emailed to BOPA members
Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…
One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future. In 2026 we received 9 nominations for 6 positions. -Standard…
We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…
Have you cast your vote for the 2026 BOPA Executive Committee Election? In 2026 we received 9 nominations for 6 positions. -Standard Committee Member (6 places available) – VOTING FOR…
The 29th BOPA Annual Conference in 2026 will be held at the ICC London Olympia on 2-4 October 2026.
Check out the latest information here: Latest Conference 2026 – BOPA
Everything you need to know
